Interestingly, the authors demonstrated that gut microbiome, and in particular A. muciniphila, influences efficacy of PD-1-based immunotherapy against epithelial tumors increasing the presence of tumor-infiltrated CCR9+CXCR3+CD4+ T cells through a IL-12-dependent signaling pathway [48]. This evidence concerns the gene PDCD1 and neoplasm.